These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3027175)

  • 1. Analysis of immune function in herpes zoster patients: demonstration and characterization of suppressor cells.
    Cauda R; Grossi CE; Whitley RJ; Tilden AB
    J Immunol; 1987 Feb; 138(4):1229-33. PubMed ID: 3027175
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine.
    Diaz PS; Smith S; Hunter E; Arvin AM
    J Immunol; 1989 Jan; 142(2):636-41. PubMed ID: 2536059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the varicella zoster virus (VZV)-specific intra-ocular T-cell response in patients with VZV-induced uveitis.
    Milikan JC; Kuijpers RW; Baarsma GS; Osterhaus AD; Verjans GM
    Exp Eye Res; 2006 Jul; 83(1):69-75. PubMed ID: 16530754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recovery of varicella-zoster virus-specific T cell immunity after T cell-depleted allogeneic transplantation requires symptomatic virus reactivation.
    Distler E; Schnürer E; Wagner E; von Auer C; Plachter B; Wehler D; Huber C; Kolbe K; Meyer RG; Herr W
    Biol Blood Marrow Transplant; 2008 Dec; 14(12):1417-24. PubMed ID: 19041065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of viral antigens recognized by ocular infiltrating T cells from patients with varicella zoster virus-induced uveitis.
    Milikan JC; Kinchington PR; Baarsma GS; Kuijpers RW; Osterhaus AD; Verjans GM
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3689-97. PubMed ID: 17652740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
    Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
    J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of NK cell-mediated lysis of varicella-zoster virus (VZV)-infected cells: characterization of the effector cells.
    Tilden AB; Cauda R; Grossi CE; Balch CM; Lakeman AD; Whitley RJ
    J Immunol; 1986 Jun; 136(11):4243-8. PubMed ID: 3009620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological parameters in multiple sclerosis patients with special reference to the herpes virus group.
    Haahr S; Møller-Larsen A; Pedersen E
    Clin Exp Immunol; 1983 Feb; 51(2):197-206. PubMed ID: 6188564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
    Schmid DS; Rouse BT
    J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of primary sensitization of naive human T cells to varicella-zoster virus peptides by dendritic cells in vitro with responses elicited in vivo by varicella vaccination.
    Jenkins DE; Yasukawa LL; Bergen R; Benike C; Engleman EG; Arvin AM
    J Immunol; 1999 Jan; 162(1):560-7. PubMed ID: 9886433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recognition of the latency-associated immediate early protein IE63 of varicella-zoster virus by human memory T lymphocytes.
    Sadzot-Delvaux C; Kinchington PR; Debrus S; Rentier B; Arvin AM
    J Immunol; 1997 Sep; 159(6):2802-6. PubMed ID: 9300702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Varicella-zoster virus-specific cell-mediated immunity in subjects with herpes zoster.
    Otani N; Yamanishi K; Sakaguchi Y; Imai Y; Shima M; Okuno T
    J Immunol Methods; 2012 Mar; 377(1-2):53-5. PubMed ID: 22261191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a gamma interferon ELISPOT assay for quantitation of cellular immune responses to varicella-zoster virus.
    Smith JG; Liu X; Kaufhold RM; Clair J; Caulfield MJ
    Clin Diagn Lab Immunol; 2001 Sep; 8(5):871-9. PubMed ID: 11527795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular immunity and herpesvirus infections in cardiac-transplant patients.
    Rand KH; Rasmussen LE; Pollard RB; Arvin A; Merigan TC
    N Engl J Med; 1977 Jun; 296(24):1372-7. PubMed ID: 193008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell imbalances and NK activity in varicella-zoster virus infections.
    Cauda R; Prasthofer EF; Tilden AB; Whitley RJ; Grossi CE
    Viral Immunol; 1987; 1(2):145-52. PubMed ID: 2978454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human immune responses to herpes simplex virus, varicella-zoster and cytomegalovirus in vitro.
    Williamson SA; Parish N; Chambers JD; Knight RA
    Immunology; 1986 Mar; 57(3):437-42. PubMed ID: 3007334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor cell function of human granular lymphocytes identified by the HNK-1 (Leu 7) monoclonal antibody.
    Tilden AB; Abo T; Balch CM
    J Immunol; 1983 Mar; 130(3):1171-5. PubMed ID: 6218202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variation in lymphoproliferative responses during recrudescent orofacial herpes simplex virus infections.
    Vestey JP; Norval M; Howie S; Maingay J; Neill WA
    Clin Exp Immunol; 1989 Sep; 77(3):384-90. PubMed ID: 2553308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes zoster pathogenesis and cell-mediated immunity and immunosenescence.
    Oxman MN
    J Am Osteopath Assoc; 2009 Jun; 109(6 Suppl 2):S13-7. PubMed ID: 19553630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.